Business Description
Torii Pharmaceutical Co Ltd
ISIN : JP3635800000
Share Class Description:
TRXPF: Ordinary SharesDescription
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 180.34 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.47 | |||||
| Beneish M-Score | -1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.4 | |||||
| 3-Year EBITDA Growth Rate | 8 | |||||
| 3-Year EPS without NRI Growth Rate | -1.7 | |||||
| 3-Year FCF Growth Rate | 4.7 | |||||
| 3-Year Book Growth Rate | 1.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.05 | |||||
| Quick Ratio | 6.19 | |||||
| Cash Ratio | 3.52 | |||||
| Days Inventory | 127.99 | |||||
| Days Sales Outstanding | 164.48 | |||||
| Days Payable | 88.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.87 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Shareholder Yield % | 3.52 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.37 | |||||
| Operating Margin % | 9.23 | |||||
| Net Margin % | 7.54 | |||||
| FCF Margin % | -6.02 | |||||
| ROE % | 3.47 | |||||
| ROA % | 3.12 | |||||
| ROIC % | 4.8 | |||||
| ROC (Joel Greenblatt) % | 17.57 | |||||
| ROCE % | 4.67 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.19 | |||||
| PE Ratio without NRI | 26.39 | |||||
| Shiller PE Ratio | 16.76 | |||||
| PS Ratio | 1.9 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 0.87 | |||||
| EV-to-EBIT | 10.72 | |||||
| EV-to-EBITDA | 10.72 | |||||
| EV-to-Revenue | 1.1 | |||||
| EV-to-FCF | -17.95 | |||||
| Price-to-Projected-FCF | 0.63 | |||||
| Price-to-Median-PS-Value | 1.23 | |||||
| Price-to-Graham-Number | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 1.39 | |||||
| Price-to-Net-Cash | 3.38 | |||||
| Earnings Yield (Greenblatt) % | 9.33 | |||||
| FCF Yield % | -3.22 | |||||
| Forward Rate of Return (Yacktman) % | -2.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TRXPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Torii Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 385.156 | ||
| EPS (TTM) ($) | 1.01 | ||
| Beta | 0.02 | ||
| Volatility % | 2.35 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 24.57 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 24.57 - 24.57 | ||
| Shares Outstanding (Mil) | 28.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Torii Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Torii Pharmaceutical Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Torii Pharmaceutical Co Ltd Frequently Asked Questions
What is Torii Pharmaceutical Co Ltd(TRXPF)'s stock price today?
The current price of TRXPF is $24.57. The 52 week high of TRXPF is $24.57 and 52 week low is $24.57.
When is next earnings date of Torii Pharmaceutical Co Ltd(TRXPF)?
The next earnings date of Torii Pharmaceutical Co Ltd(TRXPF) is .
Does Torii Pharmaceutical Co Ltd(TRXPF) pay dividends? If so, how much?
Torii Pharmaceutical Co Ltd(TRXPF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers